LMBRD1
protein-codingLMBR1 domain containing 1
Gene summary
This gene encodes a lysosomal membrane protein that may be involved in the transport and metabolism of cobalamin. This protein also interacts with the large form of the hepatitis delta antigen and may be required for the nucleocytoplasmic shuttling of the hepatitis delta virus. Mutations in this gene are associated with the vitamin B12 metabolism disorder termed, homocystinuria-megaloblastic anemia complementation type F.[provided by RefSeq, Oct 2009]
- C6orf209
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~194.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: ClinGen
LMBRD1 was first reported in relation to autosomal recessive inheritance of methylmalonic aciduria and homocystinuria type cblF in 2009 (Rutsch F, et al. PMID: 19136951). At least 10 unique loss of function variants (including nonsense, frameshift, and splicing) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 10 probands in 4 publications (PMIDs: 19136951, 32875039, 20127417, 21303734). This gene-disease relationship is supported by experimental evidence of the biochemical function in transport of ABCD4 for delivery of lysosomal vitamin B(12) to cytoplasmic MMACHC, consistent with the elevated methylmalonic acid and homocysteine phenotypes (PMID: 27456980), and rescue of the biochemical cblF phenotype in patient cells transfected with a wild-type construct (PMID: 19136951). In summary, LMBRD1 is definitively associated with autosomal recessive inheritance of methylmalonic aciduria and homocystinuria type cblF.
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0010183
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Biochemical; Cardiovascular; Dermatologic; Hematologic; Neurologic
Intervention: Biochemical
Rationale: While no treatment is completely effective, specific dietary (eg, high-calorie, low protein diet and avoidance of fasting, with measures taken to avoid/treat decompensation) and other medical measures (eg, cofactor therapy with hydroxycobalamin) may be beneficial to treat and prevent sequelae in the acute and chronic states
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to LMBRD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_018368.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 118 | 1 | 119 | |||
| missense | 153 | 4 | 157 | |||
| nonsense | 10 | 5 | 15 | |||
| start loss | 1 | 1 | ||||
| frameshift | 15 | 7 | 22 | |||
| splice donor/acceptor (+/-2bp) | 1 | 22 | 23 | |||
| Total | 26 | 35 | 153 | 122 | 1 | 337 |
Highest pathogenic variant AF is 0.0006095659
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060838.3 | 16 | MANE Select | |
| Ensembl | ENSP00000497690.1 | 16 | MANE Select | |
| RefSeq | NP_001350651.1 | 15 | Standard | |
| RefSeq | NP_001354200.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Vitamin digestion and absorption - Homo sapiens (human)
- Cobalamin (Cbl, vitamin B12) transport and metabolism
- Metabolism
- Metabolism of water-soluble vitamins and cofactors
- Metabolism of vitamins and cofactors
Biological Process
- cobalamin metabolic process
- cobalamin transport
- viral process
Molecular Function
- insulin receptor binding
- cobalamin-transporting ATPase activity
- cobalamin binding
Cellular Component
- lysosomal membrane
- plasma membrane
- membrane
- integral component of membrane
- clathrin-coated endocytic vesicle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000370577
- Coding exons
- 16
- Length
- 121310
- Individuals with no LoFs
- 125553
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 195
- Defined
- 125748
- p
- 0.000776
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.257 | 272 | 284 | 0.957 | 0.0000142 | 3512 |
| Missense (PolyPhen) | 58 | 71.069 | 0.8161 | 859 | ||
| Synonymous | 0.559 | 91 | 98.0 | 0.928 | 0.00000486 | 1005 |
| Loss of Function | 1.88 | 21 | 32.6 | 0.644 | 0.00000164 | 406 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0014 | 0.0014 | notable |
| Latino/Admixed American | 0.00044 | 0.00043 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.00074 | 0.00074 | rare |
| European (Non-Finnish) | 0.0012 | 0.0011 | notable |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00066 | 0.00065 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable lysosomal cobalamin transporter. Required to export cobalamin from lysosomes allowing its conversion to cofactors. {ECO:0000269|PubMed:19136951}.;
- Disease
- DISEASE: Methylmalonic aciduria and homocystinuria, cblF type (MAHCF) [MIM:277380]: An autosomal recessive disorder of cobalamin metabolism characterized by decreased levels of the coenzymes adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl). It is due to accumulation of free cobalamin in lysosomes, thus hindering its conversion to cofactors. Clinical features include developmental delay, stomatitis, glossitis, seizures and methylmalonic aciduria responsive to vitamin B12. {ECO:0000269|PubMed:19136951}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.103
Intolerance Scores
- LoFtool
- 0.919
- RVIS EVS
- -0.56
- RVIS percentile EVS
- 19.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.132
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |